Zusammenfassung
Die Infektionsrate des primären künstlichen Gelenkersatzes beträgt 0,5–2%. Als Risikofaktoren gelten systemische Erkrankungen wie rheumatoide Arthritis (RA) oder vorangegangene Operationen. Die Infektionsrate an dem hier präsentierten Patientengut ist gering (0,72%). Die Re-Infektionsrate (23,4%) in der vorgelegten Studie ist durch Patienten mit RA und septischen Knieendoprothesen bedingt.
Die erfolgreiche Therapie hängt von verschiedenen Faktoren ab – essenziell ist eine akkurate präoperative bakterielle Diagnostik. Die Gelenkpunktion ist das Verfahren der Wahl. Sie kann bei bestehender Unsicherheit der Diagnose durch die offene Biopsie bzw. arthroskopisch gestützte Biopsie ergänzt werden. Eine Frühinfektion kann durch ein agressives Débridement ohne Wechsel der festen Implantatkomponenten behandelt werden, die „Low-grade-Infektion“ oder die Spätinfektion werden grundsätzlich mit dem Austausch des Implantats als ein- oder zweizeitiger Wechsel gemäß klar definierten Algorithmen therapiert. Die Antibiotikakombinationstherapie mit Rifampicin ist eine Grundlage in der Behandlung.
Abstract
Periprosthetic infections are severe complications following total joint arthroplasty. The infection rate is estimated to be 0.5–2%. Systemic diseases such as rheumatoid arthritis and previous surgery are considered risk factors for infection. The infection rate in the present patient cohort was low (0.72%). The recurrence rate (23.4%) is due to patients with rheumatoid arthritis and septic total knee arthroplasties.
Successful treatment is dependent on various factors, one of which involves accurate preoperative bacterial diagnostics. Joint fluid aspiration is the appropriate procedure. Open biopsy or arthroscopically guided biopsy can be performed in cases of unclear diagnostic results. Early infection can be treated with thorough joint debridement without exchanging fixed implant components; “low-grade” or late infections require revision with implant removal in a one or two stage septic revision according to clearly determined algorithms. Antibiotic therapy is mandatory, and a combination with rifampicin is a very useful basis.
Literatur
Atkins BL, Athanasou N, Deeks JJ et al. (1998) Prospective evaluation criteria for microbiological diagnosis of prosthetic joint infection at revision arthroplasty. J Clin Microbiol 36: 2932–2939
Barrack RL (1997) The value of preoperative knee aspiration: don’t ask, don’t tell. Orthopedics 20: 862–864
Barrack RL, Jennings RW, Wolfe MW, Bertot AJ (1997) The Coventry Award. The value of perioperative aspiration before total knee revision. Clin Orthop 345: 8–16
Bengston S, Knutson K, Lidgren L (1989) Treatment of infected knee arthroplasty. Clin Orthop Relat Res 245: 173–178
Berbarif EF, Osmon DR, Duffy MC et al. (2006) Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapie in 200 episodes. Clin Infect Dis 15: 216–223
Corstens F, van de Meer J (1999) Nuclear medicine’s role in infection and inflammation. Lancet 354: 765–770
Crockarell JR, Hanssen AD, Osmon DR, Morey BF (1998) Treatment of infection with debridement and retention of the components following hip arthroplasty. J Bone Joint Surg Am 80: 1306–1313
Elek SD, Conen PE (1957) The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection. Br J Exp Pathol 138: 53–86
Fitzgerald RH Jr, Norlan DR, Ilstrup DM et al. (1996) Deep wound sepsis following total hip arthroplasty. J Bone Joint Surg Am 78: 847–855
Frommelt L (2006) Principles of systemic antimicrobial therapy in foreign material associated infection in bone tissue, with special focus on periprosthetic infection. Injury 37 (Suppl 2): S87–S94
Fuerst M, Fink B, Rüther W (2005) The value of preoperative knee aspiration and arthroscopic biopsy in revision total knee arthroplasty. Z Orthop Ihre Grenzgeb 143: 36–41
Haddad FS, Muirhead-Allwood SK, Manktelow AR, Bacarese-Hamilton I (2000) Two-stage uncemented revision hip arthroplasty for infection. J Bone Joint Surg Br 82: 689–694
Hanssen AD, Rand JA (1999) Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. Instr Course Lect 48: 111–122
James PJ, Butcher IA, Gardner ER, Hamblen DL (1994) Methicillin-resistant Staphylococcus epidermidis in infection of hip arthroplasties. J Bone Joint Surg Br 76: 725–727
Langlais F, Lambotte JC, Thomazeau H (2003) Treatment of infected hip replacement. In: Lemaire R, Herom F, Scott J (eds) European Instructional Course Lecture, vol 6. The British Society of Bone and Joint Surgery, London, pp 158–167
Ostendorf MMH, Dohert WJ, Verbout AJ, Herberts P (2003) Revisions for deep infection from the Swedish National Hip Registry: epidemiology and risk factor. Procs 70th annual meeting. American Academy Of Orthopedic Surgeons
Pons M, Angles F, Sanchez C et al. (1999) Infected total hip arhtroplasty – the value of intraoperative histology. Int Orthop 23: 34–36
Poss R, Thornhill TS, Ewald FC et al. (1984) Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clin Orthop Relat Res 182: 117–126
Razonable RR, Osmon DR, Steckelberg JM (2004) Linezolid therapie for orthopedic infections. Mayo Clinic Proc 79: 1137–1144
Saleh KJ, Clark CR, Rand JA, Brown GA (2003) Modes of failure and preoperative evaluation. J Bone Joint Surg Am 85 (Suppl 1): 21–25
Spangehl MJ, Masri BA, O’Conell JX, Duncan CP (1999) Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the site of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am 81: 672–683
Scher DM, Pak K, Lonner JH (2000) The predictive value of indium-111 leukocyte scans in the diagnosis of infected total hip, knee, or resection arthroplasties. J Arthroplasty 15: 295–300
Stumpe KD, Notzli HP, Zanetti M et al. (2004) FDG PET for differentiation of infection and aseptic loosening in total hip replacements: Comparison with conventional radiography and three-phase bone scintigraphy. Radiology 231: 377–380
Toms AD, Davidson D, Masri BA, Duncan CP (2006) The management of peri-prosthetic infection in total joint arthroplasty. J Bone Joint Surg Br 88: 149–152
Tsukayama DT, Estrada R, Gustilo RB (1996) Infection after total hip arthroplasty: a study of treatment of one hundred and six infections. J Bone Joint Surg Am 78: 512–523
Tsukayama DT, Goldberg VM, Kyle R (2003) Diagnosis and management of infection after total knee arthroplasty. J Bone Joint Surg Am 85 (Suppl 1): 75–78
White LM, Kim JK, Metha M et al. (2000) Complications of total hip arthroplasty: MR imaging-initial experience. Radiology 215: 254–262
Zimmerli W, Tramputz A, Ochsner PE (2004) Prosthetic joint infection. New Engl J Med 351: 1645–1654
Zimmerli W, Widmer AF, Blatter M et al. (1998) Role of rifampicin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 279: 1537–1541
Interessenkonflikt
Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lohmann, C., Fürst, M., Niggemeyer, O. et al. Die Behandlung von periprothetischen Infektionen. Z Rheumatol 66, 28–33 (2007). https://doi.org/10.1007/s00393-006-0141-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00393-006-0141-5